These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. The glycine transport inhibitor sarcosine is an NMDA receptor co-agonist that differs from glycine. Zhang HX; Hyrc K; Thio LL J Physiol; 2009 Jul; 587(Pt 13):3207-20. PubMed ID: 19433577 [TBL] [Abstract][Full Text] [Related]
83. The glycine transport inhibitor sarcosine is an inhibitory glycine receptor agonist. Zhang HX; Lyons-Warren A; Thio LL Neuropharmacology; 2009; 57(5-6):551-5. PubMed ID: 19619564 [TBL] [Abstract][Full Text] [Related]
84. The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice. Chen HH; Stoker A; Markou A Psychopharmacology (Berl); 2010 May; 209(4):343-50. PubMed ID: 20217053 [TBL] [Abstract][Full Text] [Related]
85. Pre-synaptic glycine GlyT1 transporter--NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions. Musante V; Summa M; Cunha RA; Raiteri M; Pittaluga A J Neurochem; 2011 May; 117(3):516-27. PubMed ID: 21348870 [TBL] [Abstract][Full Text] [Related]
90. 1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats. Popik P; Holuj M; Nikiforuk A; Kos T; Trullas R; Skolnick P Psychopharmacology (Berl); 2015 Mar; 232(6):1025-38. PubMed ID: 25260339 [TBL] [Abstract][Full Text] [Related]
91. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669 [TBL] [Abstract][Full Text] [Related]
92. Assessment of NMDA receptor activation in vivo by Fos induction after challenge with the direct NMDA agonist (tetrazol-5-yl)glycine: effects of clozapine and haloperidol. Inada K; Farrington JS; Moy SS; Koller BH; Duncan GE J Neural Transm (Vienna); 2007 Jul; 114(7):899-908. PubMed ID: 17318306 [TBL] [Abstract][Full Text] [Related]
96. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation. Duncan GE; Leipzig JN; Mailman RB; Lieberman JA Brain Res; 1998 Nov; 812(1-2):65-75. PubMed ID: 9813244 [TBL] [Abstract][Full Text] [Related]
97. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice. Wang RY; Liang X Neuropsychopharmacology; 1998 Jul; 19(1):74-85. PubMed ID: 9608579 [TBL] [Abstract][Full Text] [Related]
98. Increased hippocampal glycine uptake and cognitive dysfunction after peripheral nerve injury. Kodama D; Ono H; Tanabe M Pain; 2011 Apr; 152(4):809-817. PubMed ID: 21295405 [TBL] [Abstract][Full Text] [Related]
99. Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms. Nilsson LK; Schwieler L; Engberg G; Linderholm KR; Erhardt S Int J Neuropsychopharmacol; 2005 Sep; 8(3):329-39. PubMed ID: 15737250 [TBL] [Abstract][Full Text] [Related]
100. Glycine and D-serine decrease MK-801-induced hyperactivity in mice. Nilsson M; Carlsson A; Carlsson ML J Neural Transm (Vienna); 1997; 104(11-12):1195-205. PubMed ID: 9503265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]